Global cancer trial investigator sites have increased 50% in just five years but led to a rise in the number of poorly performing sites, new research ha.
Phesi’s artificial intelligence (AI) driven platform, Trial Accelerator, has reached a milestone and now contains global data from more than 100 million patients.
Phesi’s artificial intelligence (AI) driven platform, Trial Accelerator, has reached a milestone and now contains global data from more than 100 million patients.
Phesi publishes first edition of Digital Patient Profile Catalog to enable adoption of Digital Twins and improve patient centricity in drug developmentDigital patient profiles based on data from more than 60 million patients generate a statistical view of patient attributes including demographics, diversity, comorbi.